Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Expression profiling by high throughput sequencing | Matthew Weirauch | ||||||
GSE148396 |
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci
|
|
29 | Matthew Weirauch | Sep 23, 2021 | |||
GSE177046 |
Epstein-Barr virus nuclear antigen 2 (EBNA2) extensively rewires the human chromatin landscape at autoimmune risk loci [RNA-seq]
|
|
6 | Matthew Weirauch | Sep 23, 2021 | |||
GSE184237 |
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis [RNA-Seq]
|
|
12 | Matthew Weirauch | Apr 26, 2022 | |||
GSE184238 |
Epigenetic and Transcriptional Dysregulation in T cells of patients with Atopic Dermatitis
|
|
48 | Matthew Weirauch | Apr 26, 2022 | |||
GSE232336 |
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis and atopic dermatitis [RNA-Seq]
|
|
10 | Matthew Weirauch | Nov 26, 2023 | |||
GSE232341 |
Systematic identification of genotype-dependent enhancer variants in eosinophilic esophagitis and atopic dermatitis
|
|
39 | Matthew Weirauch | Nov 26, 2023 | |||
GSE246061 |
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome (RNA-Seq)
|
|
9 | Matthew Weirauch | Mar 12, 2024 | |||
GSE246062 |
Shared and distinct interactions of Epstein-Barr Nuclear Antigen 2 type 1 and type 2 with the human genome
|
|
43 | Matthew Weirauch | Mar 12, 2024 |